{
    "id": "New-v26-1772078249403-619",
    "stem": "The nurse is reviewing the patient's medication list. Which medications should the nurse question based on the patient's current renal function?",
    "type": "selectAll",
    "options": [
        {
            "id": "lisinopril",
            "text": "Lisinopril"
        },
        {
            "id": "metformin",
            "text": "Metformin"
        },
        {
            "id": "spironolactone",
            "text": "Spironolactone"
        },
        {
            "id": "ibuprofen",
            "text": "Ibuprofen"
        },
        {
            "id": "calciumCarbonate",
            "text": "Calcium Carbonate"
        }
    ],
    "scoring": {
        "method": "polytomous",
        "maxPoints": 1
    },
    "pedagogy": {
        "cjmmStep": "analyzeCues",
        "topicTags": [
            "General"
        ],
        "bloomLevel": "apply",
        "difficulty": 3,
        "nclexCategory": "Physiological Adaptation"
    },
    "rationale": {
        "correct": "Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that can cause further damage to the kidneys, especially in patients with pre-existing renal impairment. NSAIDs inhibit prostaglandin synthesis, leading to afferent arteriolar vasoconstriction and decreased renal blood flow. This can precipitate acute kidney injury (AKI) in susceptible individuals. Its use should be avoided or significantly limited in patients with CKD.\n\n",
        "mnemonic": {
            "AKI": "Avoid Kidney Insults (NSAIDs, ACE inhibitors/ARBs in severe stenosis, IV contrast dye)"
        },
        "incorrect": "Lisinopril, an ACE inhibitor, requires careful monitoring and potential dosage adjustment in CKD due to its impact on glomerular filtration rate. Abrupt cessation, however, could lead to uncontrolled hypertension. Metformin should be reviewed due to the risk of lactic acidosis, particularly if GFR is significantly reduced. Calcium carbonate is generally safe, though phosphorus levels should be considered to prevent hyperphosphatemia. Spironolactone, a potassium-sparing diuretic, can exacerbate hyperkalemia in patients with impaired renal function and should be used with caution.",
        "questionTrap": {
            "redHerring": "Focusing solely on medications directly affecting blood pressure or glucose without considering overall renal impact.",
            "commonMistake": "Assuming all medications on the MAR are safe without considering renal function without considering the patient's kidney function."
        },
        "clinicalPearls": [
            "NSAIDs are nephrotoxic and should be avoided in patients with CKD.",
            "Medications cleared renally require dosage adjustments based on GFR.",
            "Hyperkalemia is a common complication of CKD, exacerbated by certain medications like spironolactone.",
            "Monitor for signs of AKI (decreased urine output, increased creatinine) when administering potentially nephrotoxic medications."
        ]
    },
    "itemContext": {
        "sbar": "S: 72-year-old male with a history of CKD stage 3, admitted at 08:00 for worsening fatigue and edema. O: Renal function has declined over the past month. Patient reports decreased urine output. Relevant history includes hypertension, diabetes mellitus type 2, and heart failure. B: Patient's baseline creatinine has increased from 1.8 mg/dL to 2.5 mg/dL in the last month. Home medications include lisinopril, metformin, spironolactone, and calcium carbonate. A: Reviewing medications for potential nephrotoxic effects or dosage adjustments needed due to impaired renal clearance. Assessing for medication-related causes of AKI. R: Recommend holding ibuprofen and consulting with the nephrologist regarding dosage adjustments for lisinopril, metformin, and spironolactone.",
        "tabs": [
            {
                "id": "sbar",
                "title": "SBAR",
                "content": "S: 72-year-old male with a history of CKD stage 3, admitted at 08:00 for worsening fatigue and edema. O: Renal function has declined over the past month. Patient reports decreased urine output. Relevant history includes hypertension, diabetes mellitus type 2, and heart failure. B: Patient's baseline creatinine has increased from 1.8 mg/dL to 2.5 mg/dL in the last month. Home medications include lisinopril, metformin, spironolactone, and calcium carbonate. A: Reviewing medications for potential nephrotoxic effects or dosage adjustments needed due to impaired renal clearance. Assessing for medication-related causes of AKI. R: Recommend holding ibuprofen and consulting with the nephrologist regarding dosage adjustments for lisinopril, metformin, and spironolactone."
            },
            {
                "id": "vitals",
                "title": "Vitals",
                "content": "<table><thead><tr><th>Vital Sign</th><th>Value</th></tr></thead><tbody><tr><td>Blood Pressure</td><td>160/90 mmHg</td></tr><tr><td>Heart Rate</td><td>90 bpm</td></tr><tr><td>Respiratory Rate</td><td>20 breaths/min</td></tr><tr><td>Temperature</td><td>37.0Â°C</td></tr><tr><td>Oxygen Saturation</td><td>95% on room air</td></tr></tbody></table>"
            },
            {
                "id": "labs",
                "title": "Labs",
                "content": "<table><thead><tr><th>Lab</th><th>Value</th><th>Reference Range</th></tr></thead><tbody><tr><td>Creatinine</td><td>2.5 mg/dL</td><td>0.6-1.2 mg/dL</td></tr><tr><td>BUN</td><td>40 mg/dL</td><td>8-20 mg/dL</td></tr><tr><td>Potassium</td><td>5.8 mEq/L</td><td>3.5-5.0 mEq/L</td></tr><tr><td>GFR (estimated)</td><td>35 mL/min/1.73 m2</td><td>>60 mL/min/1.73 m2</td></tr></tbody></table>"
            },
            {
                "id": "radiology",
                "title": "Radiology",
                "content": "No recent radiology reports available."
            },
            {
                "id": "mar",
                "title": "MAR",
                "content": "<table><thead><tr><th>Medication</th><th>Dosage</th><th>Route</th><th>Frequency</th></tr></thead><tbody><tr><td>Lisinopril</td><td>20 mg</td><td>Oral</td><td>Daily</td></tr><tr><td>Metformin</td><td>500 mg</td><td>Oral</td><td>Twice daily</td></tr><tr><td>Spironolactone</td><td>25 mg</td><td>Oral</td><td>Daily</td></tr><tr><td>Ibuprofen</td><td>200 mg</td><td>Oral</td><td>PRN for pain</td></tr><tr><td>Calcium Carbonate</td><td>500 mg</td><td>Oral</td><td>Three times daily with meals</td></tr></tbody></table>"
            }
        ],
        "patient": {
            "age": 72,
            "gender": "Male",
            "diagnosis": "Chronic Kidney Disease (Stage 3)",
            "currentSymptoms": "Fatigue, peripheral edema, decreased urine output",
            "relevantHistory": "Hypertension, Diabetes Mellitus Type 2, Heart Failure"
        }
    },
    "sentinelStatus": "deep_healed_v2026",
    "correctOptionIds": [
        "ibuprofen"
    ]
}